News
ERNA
1.740
0.00%
0.000
Weekly Report: what happened at ERNA last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at ERNA last week (0408-0412)?
Weekly Report · 04/15 10:23
Weekly Report: what happened at ERNA last week (0401-0405)?
Weekly Report · 04/08 10:26
Weekly Report: what happened at ERNA last week (0325-0329)?
Weekly Report · 04/01 10:25
Weekly Report: what happened at ERNA last week (0318-0322)?
Weekly Report · 03/25 10:27
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Several key companies are set to release their earnings reports for the week of March 25 to 29. Walgreens Boots Alliance, Carnival, GameStop and more are among the companies scheduled to report next week. The week is shortened by a market holiday on Friday and will be shortened to one day.
Seeking Alpha · 03/24 12:01
Weekly Report: what happened at ERNA last week (0311-0315)?
Weekly Report · 03/18 10:26
ISRG Stock Alert: The FDA Is Giving Intuitive Surgical a Big Boost
Intuitive Surgical (ISRG) stock is up 1.3% as of Friday morning. The company is preparing to launch the da Vinci 5 robotic system in the U.S. And globally. Rivian (RIVN), Kopin (KOPN) and Eterna Therapeutics (ERNA) are among the stocks moving today.
Investorplace · 03/15 13:41
ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q4 2023
Eterna Therapeutics reported earnings per share of -$1.14. The company reported revenue of $17,000. Eterna is a biotechnology company that is developing a drug to treat cancer in the U.S. The stock was down 2.7% to $3.05 in the afternoon.
Investorplace · 03/15 12:53
Weekly Report: what happened at ERNA last week (0304-0308)?
Weekly Report · 03/11 10:24
Weekly Report: what happened at ERNA last week (0226-0301)?
Weekly Report · 03/04 10:26
Weekly Report: what happened at ERNA last week (0219-0223)?
Weekly Report · 02/26 10:34
Press Release: Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors. Eterna is a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines. Mr. Cical a has deep experience in the biotechnology and pharmaceutical industry.
Dow Jones · 02/20 13:30
Weekly Report: what happened at ERNA last week (0212-0216)?
Weekly Report · 02/19 10:35
Eterna Therapeutics Welcomes New Board Member Peter Cicala
TipRanks · 02/16 12:42
Weekly Report: what happened at ERNA last week (0205-0209)?
Weekly Report · 02/12 10:29
Weekly Report: what happened at ERNA last week (0129-0202)?
Weekly Report · 02/05 10:34
12 Health Care Stocks Moving In Friday's Pre-Market Session
Revance Therapeutics shares moved upwards by 16.5% to $6.0 during Friday's pre-market session. The company's market cap stands at $526.8 million. Connect Biopharma Hldgs (NASDAQ:CNTB) shares rose 14.85% during the session. GRI Bio and Sharps Technology were among the losers in the day's trading.
Benzinga · 02/02 13:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Kiora Pharmaceuticals (NASDAQ:KPRX) stock rose 48.3% to $0.82 during Thursday's pre-market session. Salarius Pharmaceuticals and Akso Health Group were among the gainers. Revelation Biosciences stock decreased by 59.7% during the session.
Benzinga · 02/01 13:06
Weekly Report: what happened at ERNA last week (0122-0126)?
Weekly Report · 01/29 10:27
More
Webull provides a variety of real-time ERNA stock news. You can receive the latest news about Eterna Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About ERNA
Eterna Therapeutics Inc. is a life science company committed to realizing the potential of messenger ribonucleic acid (RNA) (mRNA) cell engineering to provide patients with transformational new medicines. The Company has in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system (collectively mRNA technology platform). Its mRNA gene-editing technology is designed to delete, insert and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.